News Related to Chronic Inflammatory Diseases

Related coverage linked through entity extraction aliases.

FDA Plans to Ease Biosimilar Testing Requirements as Market Expands

Mar 11, 2026

The FDA is expected to issue draft guidance reducing testing requirements for biosimilar drugs, potentially lowering development costs by USD 20 million. The move comes as the biosimilars market shows strong growth, with major launches in 2025.

Abivax Presents First Anti-Fibrotic Evidence for Obefazimod at ECCO 2026

Feb 21, 2026

Abivax announced novel preclinical and clinical data for obefazimod at ECCO 2026, highlighting anti-fibrotic potential in Crohn's disease, favorable safety profile, and rapid onset of symptomatic relief in inflammatory bowel disease patients.